SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalBiotech News


Previous 10 Next 10 
From: tnsaf1/30/2017 6:31:50 PM
1 Recommendation   of 7143
 
"The nervous and immune systems communicate and reciprocally influence their functional responses. Nature Immunology and Nature Neuroscience team up to present a joint focus issue comprising of specially commissioned review articles that examine how the nervous system and immune cells interact during development, during homeostasis and in pathogenic disease states."

nature.com

Share RecommendKeepReplyMark as Last Read


From: idos3/25/2017 3:27:40 AM
1 Recommendation   of 7143
 
Sinclair is doing the Sirtris thing again?!

time.com

Share RecommendKeepReplyMark as Last Read


From: nigel bates4/7/2017 6:54:40 AM
   of 7143
 
RNA editing in coleoid cephalopods:
theatlantic.com

Share RecommendKeepReplyMark as Last Read


From: nigel bates5/6/2017 8:30:38 AM
   of 7143
 
Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism
pnas.org

Abstract
Effective control of endotoxins and bacteria is crucial for normal wound healing. During injury, the key enzyme thrombin is formed, leading to generation of fibrin. Here, we show that human neutrophil elastase cleaves thrombin, generating 11-kDa thrombin-derived C-terminal peptides (TCPs), which bind to and form amorphous amyloid-like aggregates with both bacterial lipopolysaccharide (LPS) and gram-negative bacteria. In silico molecular modeling using atomic resolution and coarse-grained simulations corroborates our experimental observations, altogether indicating increased aggregation through LPS-mediated intermolecular contacts between clusters of TCP molecules. Upon bacterial aggregation, recombinantly produced TCPs induce permeabilization of Escherichia coli and phagocytic uptake. TCPs of about 11 kDa are present in acute wound fluids as well as in fibrin sloughs from patients with infected wounds. We noted aggregation and colocalization of LPS with TCPs in such fibrin material, which indicates the presence of TCP-LPS aggregates under physiological conditions. Apart from identifying a function of proteolyzed thrombin and its fragments, our findings provide an interesting link between the coagulation system, innate immunity, LPS scavenging, and protein aggregation/amyloid formation.

Share RecommendKeepReplyMark as Last Read


From: IRWIN JAMES FRANKEL5/22/2017 9:14:04 AM
   of 7143
 
Healing wounds without scaring. Early animal study but interesting if it translates to humans.

newscientist.com

Share RecommendKeepReplyMark as Last Read


From: DewDiligence_on_SI8/23/2017 6:20:36 PM
   of 7143
 
ADXS (belatedly) shows AXAL/Durvalumab phase-2 data in cervical/H&N cancers: investorshub.advfn.com

Share RecommendKeepReplyMark as Last Read


From: tnsaf9/24/2017 6:06:30 PM
   of 7143
 
The garbage masquerading as information on websites can be quite humorous. For example, this one appears to combines a template with a database that fills in blanks, but some of the fields in the database are empty: economicsandmoney.com.

Share RecommendKeepReplyMark as Last Read


From: DewDiligence_on_SI3/18/2018 3:05:10 PM
   of 7143
 
RVNC apparently has the Botox cell line: investorshub.advfn.com

Share RecommendKeepReplyMark as Last Read


From: tnsaf5/23/2018 4:46:26 PM
   of 7143
 
Diabetes Researchers Find Switch for Fatty Liver Disease
Interesting article in DDD Magazine on this topic

Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and prediabetes.

dddmag.com

Share RecommendKeepReplyMark as Last Read


From: Sultan7/3/2018 1:22:18 PM
   of 7143
 
Antibe Therapeutics Releases Secondary Endpoint Data from Recent Phase 2B Gastrointestinal Safety Study for Lead Drug, ATB-346

finance.yahoo.com

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10